The Food and Drug Administration conducted an inspection at Mylan Pharmaceuticals, Inc. in Morgantown on April 28 for drug quality assurance , according to data available on the FDA’s website.
The final report concluded that Mylan Pharmaceuticals, Inc. was not required to make changes to its management operations.
The FDA regularly inspects facilities nationwide to ensure workplaces and products comply with FDA-regulated laws and standards aimed at protecting public health. Results from these inspections are made publicly accessible.
The agency’s website notes the FDA oversees the safety and quality of human and animal drugs, biologics, medical products and tobacco goods across the United States.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
